Trinity Biotech (TRIB) EBT Growth (5y) (2014 - 2024)
Trinity Biotech (TRIB) EBT Growth (5y) (2014 - 2024) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn |
| 10 | Trinity Biotech | 6.82 Mn | 1.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 12.34% |
| Sep 30, 2024 | -89.94% |
| Jun 30, 2024 | -134.03% |
| Mar 31, 2024 | -76.19% |
| Dec 31, 2023 | 26.20% |
| Sep 30, 2023 | -83.07% |
| Jun 30, 2023 | -92.40% |
| Mar 31, 2023 | -56.58% |
| Dec 31, 2022 | 24.18% |
| Sep 30, 2022 | -81.06% |
| Jun 30, 2022 | -69.07% |
| Mar 31, 2022 | -113.12% |
| Dec 31, 2021 | -20.50% |
| Sep 30, 2021 | -1.78% |
| Jun 30, 2021 | -15.91% |
| Mar 31, 2021 | 41.54% |
| Dec 31, 2020 | -46.22% |
| Sep 30, 2020 | -8.98% |
| Jun 30, 2020 | -9.95% |
| Mar 31, 2020 | -7.27% |